Inscobee Inc. - 10%+ Owner at Apimeds Pharmaceuticals US, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Issuer Symbol: APUS on NYSE
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Inscobee Inc. since 26 May 2025

Holdings reported by Inscobee Inc. for Apimeds Pharmaceuticals US, Inc.

Form 4 holding 10%+ Owner

Apimeds Pharmaceuticals US, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 4,316,618
Estimated value: $8,805,900
Report date: 12 May 2024
Price: $2.04
Ownership: By Apimeds Inc.

Form 4 holding 10%+ Owner

Apimeds Pharmaceuticals US, Inc.

Security class: Convertible Promissory Note
Shares / value: 0
Estimated value
Report date: 12 May 2025
Price
Ownership: By Apimeds Inc.
Underlying class: Common Stock, par value $0.01 per share
Underlying amount

Form 4 holding 10%+ Owner

Apimeds Pharmaceuticals US, Inc.

Security class: Convertible Promissory Note
Shares / value: 0
Estimated value
Report date: 12 May 2025
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount

Transactions reported by Inscobee Inc. for Apimeds Pharmaceuticals US, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .